カテゴリ： 世界, 医療/バイオ, QYResearch

患者由来異種移植（PDX）モデルの世界市場2023年：マウスモデル、ラットモデル

■ 英語タイトル：Global Patient-derived Xenograft (PDX) Models Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6477）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6477
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[患者由来異種移植（PDX）モデルの世界市場2023年：マウスモデル、ラットモデル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は患者由来異種移植（PDX）モデルのグローバル市場について調査・分析し、世界の患者由来異種移植（PDX）モデル市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（マウスモデル、ラットモデル）、用途別セグメント分析（前臨床創薬、バイオマーカー解析）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Crown Bioscience、Champions Oncology、Wuxi Apptec、The Jackson Laboratory、EPO Berlin-Buch、Oncodesign、Xentech、Envigo、Charles River Laboratories、Pharmatest Services、Urosphere、MEDICILON、Horizon Discovery、Shanghai Model Organisms Center、GemPharmatech、LIDE Biotechなどが含まれています。患者由来異種移植（PDX）モデルのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、患者由来異種移植（PDX）モデル市場規模を算出する際に考慮しました。

・患者由来異種移植（PDX）モデル市場の概要
- 患者由来異種移植（PDX）モデルの種類別セグメント
- 世界の患者由来異種移植（PDX）モデル市場規模：タイプ別分析（マウスモデル、ラットモデル）
- 患者由来異種移植（PDX）モデルの用途別セグメント
- 世界の患者由来異種移植（PDX）モデル市場規模：用途別分析（前臨床創薬、バイオマーカー解析）
- 世界の患者由来異種移植（PDX）モデル市場規模予測（2018年-2029年）

・患者由来異種移植（PDX）モデル市場の成長トレンド
- 患者由来異種移植（PDX）モデルの地域別市場規模（2018年-2029年）
- 患者由来異種移植（PDX）モデル市場ダイナミクス
- 患者由来異種移植（PDX）モデルの業界動向
- 患者由来異種移植（PDX）モデル市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：マウスモデル、ラットモデル
- 世界の患者由来異種移植（PDX）モデルのタイプ別市場規模（2018年-2023年）
- 世界の患者由来異種移植（PDX）モデルのタイプ別市場規模（2024年-2029年）

・用途別セグメント：前臨床創薬、バイオマーカー解析
- 世界の患者由来異種移植（PDX）モデルの用途別市場規模（2018年-2023年）
- 世界の患者由来異種移植（PDX）モデルの用途別市場規模（2024年-2029年）

・患者由来異種移植（PDX）モデルの地域別市場規模
- 北米の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 米国の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- ヨーロッパの患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- アジア太平洋の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 中国の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 日本の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 韓国の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- インドの患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- オーストラリアの患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 中南米の患者由来異種移植（PDX）モデル市場規模（2018年-2029年）
- 中東・アフリカの患者由来異種移植（PDX）モデル市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Crown Bioscience、Champions Oncology、Wuxi Apptec、The Jackson Laboratory、EPO Berlin-Buch、Oncodesign、Xentech、Envigo、Charles River Laboratories、Pharmatest Services、Urosphere、MEDICILON、Horizon Discovery、Shanghai Model Organisms Center、GemPharmatech、LIDE Biotech

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Patient-derived Xenograft (PDX) Models market was valued at US$ 360 million in 2022 and is anticipated to reach US$ 588.6 million by 2029, witnessing a CAGR of 8.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Patient-derived Xenograft (PDX) Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Patient-derived Xenograft (PDX) Models.
The Patient-derived Xenograft (PDX) Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Patient-derived Xenograft (PDX) Models market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Patient-derived Xenograft (PDX) Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
Segment by Type
Mouse Model
Rat Model
Segment by Application
Preclinical Drug development
Biomarker Analysis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Patient-derived Xenograft (PDX) Models companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mouse Model
1.2.3 Rat Model
1.3 Market by Application
1.3.1 Global Patient-derived Xenograft (PDX) Models Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Preclinical Drug development
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patient-derived Xenograft (PDX) Models Market Perspective (2018-2029)
2.2 Patient-derived Xenograft (PDX) Models Growth Trends by Region
2.2.1 Global Patient-derived Xenograft (PDX) Models Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Patient-derived Xenograft (PDX) Models Historic Market Size by Region (2018-2023)
2.2.3 Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2024-2029)
2.3 Patient-derived Xenograft (PDX) Models Market Dynamics
2.3.1 Patient-derived Xenograft (PDX) Models Industry Trends
2.3.2 Patient-derived Xenograft (PDX) Models Market Drivers
2.3.3 Patient-derived Xenograft (PDX) Models Market Challenges
2.3.4 Patient-derived Xenograft (PDX) Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue
3.1.1 Global Top Patient-derived Xenograft (PDX) Models Players by Revenue (2018-2023)
3.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Players (2018-2023)
3.2 Global Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient-derived Xenograft (PDX) Models Revenue
3.4 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio
3.4.1 Global Patient-derived Xenograft (PDX) Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient-derived Xenograft (PDX) Models Revenue in 2022
3.5 Patient-derived Xenograft (PDX) Models Key Players Head office and Area Served
3.6 Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
3.7 Date of Enter into Patient-derived Xenograft (PDX) Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient-derived Xenograft (PDX) Models Breakdown Data by Type
4.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Type (2018-2023)
4.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2024-2029)
5 Patient-derived Xenograft (PDX) Models Breakdown Data by Application
5.1 Global Patient-derived Xenograft (PDX) Models Historic Market Size by Application (2018-2023)
5.2 Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Patient-derived Xenograft (PDX) Models Market Size (2018-2029)
6.2 North America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patient-derived Xenograft (PDX) Models Market Size (2018-2029)
7.2 Europe Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size (2018-2029)
8.2 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023)
8.4 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patient-derived Xenograft (PDX) Models Market Size (2018-2029)
9.2 Latin America Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
9.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size (2018-2029)
10.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023)
10.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Introduction
11.1.4 Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.1.5 Crown Bioscience Recent Development
11.2 Champions Oncology
11.2.1 Champions Oncology Company Detail
11.2.2 Champions Oncology Business Overview
11.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Introduction
11.2.4 Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.2.5 Champions Oncology Recent Development
11.3 Wuxi Apptec
11.3.1 Wuxi Apptec Company Detail
11.3.2 Wuxi Apptec Business Overview
11.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Introduction
11.3.4 Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.3.5 Wuxi Apptec Recent Development
11.4 The Jackson Laboratory
11.4.1 The Jackson Laboratory Company Detail
11.4.2 The Jackson Laboratory Business Overview
11.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Introduction
11.4.4 The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.4.5 The Jackson Laboratory Recent Development
11.5 EPO Berlin-Buch
11.5.1 EPO Berlin-Buch Company Detail
11.5.2 EPO Berlin-Buch Business Overview
11.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Introduction
11.5.4 EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.5.5 EPO Berlin-Buch Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Detail
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Introduction
11.6.4 Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.6.5 Oncodesign Recent Development
11.7 Xentech
11.7.1 Xentech Company Detail
11.7.2 Xentech Business Overview
11.7.3 Xentech Patient-derived Xenograft (PDX) Models Introduction
11.7.4 Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.7.5 Xentech Recent Development
11.8 Envigo
11.8.1 Envigo Company Detail
11.8.2 Envigo Business Overview
11.8.3 Envigo Patient-derived Xenograft (PDX) Models Introduction
11.8.4 Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.8.5 Envigo Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Detail
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Introduction
11.9.4 Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.9.5 Charles River Laboratories Recent Development
11.10 Pharmatest Services
11.10.1 Pharmatest Services Company Detail
11.10.2 Pharmatest Services Business Overview
11.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Introduction
11.10.4 Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.10.5 Pharmatest Services Recent Development
11.11 Urosphere
11.11.1 Urosphere Company Detail
11.11.2 Urosphere Business Overview
11.11.3 Urosphere Patient-derived Xenograft (PDX) Models Introduction
11.11.4 Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.11.5 Urosphere Recent Development
11.12 MEDICILON
11.12.1 MEDICILON Company Detail
11.12.2 MEDICILON Business Overview
11.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Introduction
11.12.4 MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.12.5 MEDICILON Recent Development
11.13 Horizon Discovery
11.13.1 Horizon Discovery Company Detail
11.13.2 Horizon Discovery Business Overview
11.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Introduction
11.13.4 Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.13.5 Horizon Discovery Recent Development
11.14 Shanghai Model Organisms Center
11.14.1 Shanghai Model Organisms Center Company Detail
11.14.2 Shanghai Model Organisms Center Business Overview
11.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Introduction
11.14.4 Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.14.5 Shanghai Model Organisms Center Recent Development
11.15 GemPharmatech
11.15.1 GemPharmatech Company Detail
11.15.2 GemPharmatech Business Overview
11.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Introduction
11.15.4 GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.15.5 GemPharmatech Recent Development
11.16 LIDE Biotech
11.16.1 LIDE Biotech Company Detail
11.16.2 LIDE Biotech Business Overview
11.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Introduction
11.16.4 LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023)
11.16.5 LIDE Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Mouse Model
Table 3. Key Players of Rat Model
Table 4. Global Patient-derived Xenograft (PDX) Models Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Patient-derived Xenograft (PDX) Models Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2018-2023)
Table 8. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Patient-derived Xenograft (PDX) Models Market Share by Region (2024-2029)
Table 10. Patient-derived Xenograft (PDX) Models Market Trends
Table 11. Patient-derived Xenograft (PDX) Models Market Drivers
Table 12. Patient-derived Xenograft (PDX) Models Market Challenges
Table 13. Patient-derived Xenograft (PDX) Models Market Restraints
Table 14. Global Patient-derived Xenograft (PDX) Models Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Patient-derived Xenograft (PDX) Models Market Share by Players (2018-2023)
Table 16. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2022)
Table 17. Ranking of Global Top Patient-derived Xenograft (PDX) Models Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Patient-derived Xenograft (PDX) Models Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Patient-derived Xenograft (PDX) Models Product Solution and Service
Table 21. Date of Enter into Patient-derived Xenograft (PDX) Models Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Patient-derived Xenograft (PDX) Models Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2018-2023)
Table 25. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Type (2024-2029)
Table 27. Global Patient-derived Xenograft (PDX) Models Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2018-2023)
Table 29. Global Patient-derived Xenograft (PDX) Models Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Application (2024-2029)
Table 31. North America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country (2024-2029) & (US$ Million)
Table 46. Crown Bioscience Company Detail
Table 47. Crown Bioscience Business Overview
Table 48. Crown Bioscience Patient-derived Xenograft (PDX) Models Product
Table 49. Crown Bioscience Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 50. Crown Bioscience Recent Development
Table 51. Champions Oncology Company Detail
Table 52. Champions Oncology Business Overview
Table 53. Champions Oncology Patient-derived Xenograft (PDX) Models Product
Table 54. Champions Oncology Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 55. Champions Oncology Recent Development
Table 56. Wuxi Apptec Company Detail
Table 57. Wuxi Apptec Business Overview
Table 58. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product
Table 59. Wuxi Apptec Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 60. Wuxi Apptec Recent Development
Table 61. The Jackson Laboratory Company Detail
Table 62. The Jackson Laboratory Business Overview
Table 63. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product
Table 64. The Jackson Laboratory Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 65. The Jackson Laboratory Recent Development
Table 66. EPO Berlin-Buch Company Detail
Table 67. EPO Berlin-Buch Business Overview
Table 68. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product
Table 69. EPO Berlin-Buch Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 70. EPO Berlin-Buch Recent Development
Table 71. Oncodesign Company Detail
Table 72. Oncodesign Business Overview
Table 73. Oncodesign Patient-derived Xenograft (PDX) Models Product
Table 74. Oncodesign Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 75. Oncodesign Recent Development
Table 76. Xentech Company Detail
Table 77. Xentech Business Overview
Table 78. Xentech Patient-derived Xenograft (PDX) Models Product
Table 79. Xentech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 80. Xentech Recent Development
Table 81. Envigo Company Detail
Table 82. Envigo Business Overview
Table 83. Envigo Patient-derived Xenograft (PDX) Models Product
Table 84. Envigo Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 85. Envigo Recent Development
Table 86. Charles River Laboratories Company Detail
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product
Table 89. Charles River Laboratories Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 90. Charles River Laboratories Recent Development
Table 91. Pharmatest Services Company Detail
Table 92. Pharmatest Services Business Overview
Table 93. Pharmatest Services Patient-derived Xenograft (PDX) Models Product
Table 94. Pharmatest Services Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 95. Pharmatest Services Recent Development
Table 96. Urosphere Company Detail
Table 97. Urosphere Business Overview
Table 98. Urosphere Patient-derived Xenograft (PDX) Models Product
Table 99. Urosphere Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 100. Urosphere Recent Development
Table 101. MEDICILON Company Detail
Table 102. MEDICILON Business Overview
Table 103. MEDICILON Patient-derived Xenograft (PDX) Models Product
Table 104. MEDICILON Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 105. MEDICILON Recent Development
Table 106. Horizon Discovery Company Detail
Table 107. Horizon Discovery Business Overview
Table 108. Horizon Discovery Patient-derived Xenograft (PDX) Models Product
Table 109. Horizon Discovery Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 110. Horizon Discovery Recent Development
Table 111. Shanghai Model Organisms Center Company Detail
Table 112. Shanghai Model Organisms Center Business Overview
Table 113. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product
Table 114. Shanghai Model Organisms Center Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 115. Shanghai Model Organisms Center Recent Development
Table 116. GemPharmatech Company Detail
Table 117. GemPharmatech Business Overview
Table 118. GemPharmatech Patient-derived Xenograft (PDX) Models Product
Table 119. GemPharmatech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 120. GemPharmatech Recent Development
Table 121. LIDE Biotech Company Detail
Table 122. LIDE Biotech Business Overview
Table 123. LIDE Biotech Patient-derived Xenograft (PDX) Models Product
Table 124. LIDE Biotech Revenue in Patient-derived Xenograft (PDX) Models Business (2018-2023) & (US$ Million)
Table 125. LIDE Biotech Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient-derived Xenograft (PDX) Models Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Patient-derived Xenograft (PDX) Models Market Share by Type: 2022 VS 2029
Figure 3. Mouse Model Features
Figure 4. Rat Model Features
Figure 5. Global Patient-derived Xenograft (PDX) Models Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Patient-derived Xenograft (PDX) Models Market Share by Application: 2022 VS 2029
Figure 7. Preclinical Drug development Case Studies
Figure 8. Biomarker Analysis Case Studies
Figure 9. Patient-derived Xenograft (PDX) Models Report Years Considered
Figure 10. Global Patient-derived Xenograft (PDX) Models Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Patient-derived Xenograft (PDX) Models Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Patient-derived Xenograft (PDX) Models Market Share by Region: 2022 VS 2029
Figure 13. Global Patient-derived Xenograft (PDX) Models Market Share by Players in 2022
Figure 14. Global Top Patient-derived Xenograft (PDX) Models Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient-derived Xenograft (PDX) Models as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2022
Figure 16. North America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2029)
Figure 18. United States Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2029)
Figure 22. Germany Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Patient-derived Xenograft (PDX) Models Market Share by Region (2018-2029)
Figure 30. China Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2029)
Figure 38. Mexico Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Patient-derived Xenograft (PDX) Models Market Share by Country (2018-2029)
Figure 42. Turkey Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Crown Bioscience Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 45. Champions Oncology Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 46. Wuxi Apptec Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 47. The Jackson Laboratory Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 48. EPO Berlin-Buch Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 49. Oncodesign Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 50. Xentech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 51. Envigo Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 52. Charles River Laboratories Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 53. Pharmatest Services Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 54. Urosphere Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 55. MEDICILON Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 56. Horizon Discovery Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 57. Shanghai Model Organisms Center Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 58. GemPharmatech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 59. LIDE Biotech Revenue Growth Rate in Patient-derived Xenograft (PDX) Models Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 患者モニター用付属品の世界市場2023年：Spo2 センサー/Spo2 延長ケーブル、EKG ケーブル/ECG 電極、ESU ケーブル、NIBP CUFF/NIBP ホース、IBP ケーブル/DPT ケーブル、その他
  • 患者モニタリング用付属品の世界市場2023年：Spo2 センサー/Spo2 延長ケーブル、EKG ケーブル/ECG 電極、ESU ケーブル、NIBP CUFF/NIBP ホース、IBP ケーブル/DPT ケーブル、その他
  • ロボット患者ポジショニングソリューションの世界市場2023年：ハードウェアデバイス、ソフトウェアサービス
  • 3D印刷外科モデルのグローバル市場（2022年-2029年）：心臓手術/介入心臓病科、食道用消化器内視鏡検査、脳神経外科、整形外科、その他
  • Casヌクレアーゼの世界市場2023年：Cas9、Cas12、Cas13、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6477 )"患者由来異種移植（PDX）モデルの世界市場2023年：マウスモデル、ラットモデル" (英文：Global Patient-derived Xenograft (PDX) Models Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。